Taylor Frigon Capital Management’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.36M Buy
132,009
+108
+0.1% +$1.35K 1.1% 35
2026
Q1
$1.2M Sell
131,901
-517
-0.4% -$6.53K 0.68% 86
2025
Q4
$1.81M Sell
132,418
-1,606
-1% -$29.8K 0.92% 56
2025
Q3
$2.92M Sell
134,024
-46,425
-26% -$547K 1.45% 15
2025
Q2
$2.15M Sell
180,449
-11,211
-6% -$141K 1.15% 41
2025
Q1
$2.28M Sell
191,660
-20,586
-10% -$320K 1.36% 16
2024
Q4
$3.26M Sell
212,246
-162,551
-43% -$2.11M 1.65% 17
2024
Q3
$4.2M Sell
374,797
-49,738
-12% -$476K 2.09% 5
2024
Q2
$2.29M Buy
424,535
+438
+0.1% +$2.54K 1.09% 35
2024
Q1
$2.88M Buy
424,097
+71,491
+20% +$500K 1.37% 30
2023
Q4
$2.39M Sell
352,606
-1,262
-0.4% -$7.14K 1.2% 32
2023
Q3
$1.77M Buy
353,868
+107,441
+44% +$639K 0.99% 41
2023
Q2
$1.78M Buy
246,427
+78,438
+47% +$667K 0.87% 46
2023
Q1
$1.42M Sell
167,989
-3,725
-2% -$32.6K 0.77% 57
2022
Q4
$1.45M Sell
171,714
-7,066
-4% -$67K 0.83% 47
2022
Q3
$1.85M Buy
178,780
+4,054
+2% +$53.4K 0.97% 42
2022
Q2
$2.28M Sell
174,726
-6,603
-4% -$67.5K 1.19% 33
2022
Q1
$1.89M Buy
181,329
+6,176
+4% +$56.2K 0.7% 51
2021
Q4
$1.97M Sell
175,153
-1,111
-0.6% -$16.6K 0.62% 51
2021
Q3
$3.13M Buy
176,264
+574
+0.3% +$10.8K 1.01% 44
2021
Q2
$3.35M Buy
175,690
+119,773
+214% +$2.31M 1.05% 44
2021
Q1
$1.18M Buy
+55,917
New +$1.2M 0.36% 69

Other funds holding CLPT

Taylor Frigon Capital Management's CLPT Position: Q2 2026 in Review

Taylor Frigon Capital Management increased its ClearPoint Neuro (CLPT) stake by 0.08% in Q2 2026, buying an estimated $1.35K and bringing the position to 132,009 shares worth $2.36M. The position accounts for 1.1% of the portfolio, ranked #35.

Taylor Frigon Capital Management first reported a position in CLPT in Q1 2021 and has held it in 22 quarters since. The position peaked at $4.2M in Q3 2024. 21 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Taylor Frigon Capital Management held 132,009 shares of ClearPoint Neuro worth $2.36M as of Q2 2026.
  • Taylor Frigon Capital Management bought 108 ClearPoint Neuro shares in Q2 2026, an estimated $1.35K.
  • ClearPoint Neuro made up 1.1% of Taylor Frigon Capital Management's portfolio in Q2 2026, its #35 holding.
  • Taylor Frigon Capital Management first reported a position in ClearPoint Neuro in Q1 2021 and has held it in 22 quarters since.
  • Taylor Frigon Capital Management's ClearPoint Neuro position peaked at $4.2M in Q3 2024.
  • 21 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Taylor Frigon Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.